美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=AMOXIL
符合检索条件的记录共19
2 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称AMOXIL
申请号050459产品号001
活性成分AMOXICILLIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
2药品名称AMOXIL
申请号050459产品号002
活性成分AMOXICILLIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
3药品名称AMOXIL
申请号050460产品号001
活性成分AMOXICILLIN市场状态停止上市
剂型或给药途径FOR SUSPENSION;ORAL规格125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
4药品名称AMOXIL
申请号050460产品号002
活性成分AMOXICILLIN市场状态停止上市
剂型或给药途径FOR SUSPENSION;ORAL规格250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
5药品名称AMOXIL
申请号050460产品号005
活性成分AMOXICILLIN市场状态停止上市
剂型或给药途径FOR SUSPENSION;ORAL规格50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构GLAXOSMITHKLINE
6药品名称AMOXIL
申请号050542产品号001
活性成分AMOXICILLIN市场状态处方药
剂型或给药途径TABLET, CHEWABLE;ORAL规格250MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构DR REDDYS LABORATORIES INC
7药品名称AMOXIL
申请号050542产品号002
活性成分AMOXICILLIN市场状态处方药
剂型或给药途径TABLET, CHEWABLE;ORAL规格125MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构DR REDDYS LABORATORIES INC
8药品名称AMOXIL
申请号050754产品号001
活性成分AMOXICILLIN市场状态处方药
剂型或给药途径TABLET;ORAL规格875MG
治疗等效代码AB参比药物
批准日期1998/07/10申请机构DR REDDYS LABORATORIES INC
9药品名称AMOXIL
申请号050754产品号002
活性成分AMOXICILLIN市场状态处方药
剂型或给药途径TABLET;ORAL规格500MG
治疗等效代码AB参比药物
批准日期1998/07/10申请机构DR REDDYS LABORATORIES INC
10药品名称AMOXIL
申请号050760产品号001
活性成分AMOXICILLIN市场状态处方药
剂型或给药途径FOR SUSPENSION;ORAL规格200MG/5ML
治疗等效代码AB参比药物
批准日期1999/04/15申请机构DR REDDYS LABORATORIES INC